- |||||||||| Leukine (sargramostim) / Partner Therap
Trial primary completion date: Study of the Safety & Efficacy of Leukine (clinicaltrials.gov) - Feb 2, 2015 P2, N=40, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Jan 2015 --> Jan 2016
- |||||||||| Leukine (sargramostim) / Partner Therap, Yervoy (ipilimumab) / BMS
Trial initiation date: Ipilimumab and GMCSF Immunotherapy for Prostate Cancer (clinicaltrials.gov) - Jan 12, 2015 P2, N=54, Not yet recruiting, Active, not recruiting --> Completed | Trial primary completion date: May 2016 --> Dec 2014 Initiation date: Aug 2014 --> Mar 2015
- |||||||||| Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma (clinicaltrials.gov) - Dec 24, 2014 P2, N=0, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2013 --> Mar 2014 Active, not recruiting --> Completed
- |||||||||| BiovaxID (dasiprotimut-T) / National Cancer Institute, Accentia
Trial primary completion date: Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma (clinicaltrials.gov) - Dec 19, 2014 P2, N=26, Active, not recruiting, Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Aug 2005
- |||||||||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health, Leukine (sargramostim) / Partner Therap
Trial completion, Surgery, Metastases: Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma (clinicaltrials.gov) - Dec 19, 2014 P1, N=0, Completed, Trial primary completion date: Jun 2017 --> Aug 2005 Active, not recruiting --> Completed
- |||||||||| BiovaxID (dasiprotimut-T) / National Cancer Institute, Accentia
Enrollment closed, Trial primary completion date: Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma (clinicaltrials.gov) - Dec 17, 2014 P2, N=26, Active, not recruiting, Active, not recruiting --> Completed | N=54 --> 40 Completed --> Active, not recruiting | Trial primary completion date: Aug 2005 --> Jun 2017
- |||||||||| Recentin (cediranib) / AstraZeneca
Trial primary completion date, Monotherapy, Metastases: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) - Dec 9, 2014 P2, N=70, Recruiting, Not yet recruiting --> Recruiting Trial primary completion date: Jun 2015 --> Apr 2016
- |||||||||| UV1 / Ultimovacs
Enrollment closed, Trial primary completion date, Metastases: A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer (clinicaltrials.gov) - Dec 9, 2014 P1/2, N=21, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jul 2015
- |||||||||| Leukine (sargramostim) / Partner Therap
Trial primary completion date: Leukine (Sargramostim) for Parkinson's Disease (clinicaltrials.gov) - Sep 19, 2014 P1, N=32, Recruiting, Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Sep 2014 | Trial primary completion date: May 2020 --> Sep 2020 Trial primary completion date: Jan 2015 --> Sep 2015
|